Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    0.00 (0.00%)
Bid:
16.45
Ask:
16.80
Spread: 0.35 (2.128%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Trading Update

1 Oct 2012 13:14

RNS Number : 6068N
Allocate Software PLC
01 October 2012
 



 

1 October 2012

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Trading Update

 

Allocate Software, (AIM: ALL), the leading provider of workforce optimisation and corporate governance, risk & compliance software gives the following update on trading for the first three months of the current financial year ending 31 May 2013.

 

New licence sales have been lower than expected during the first quarter, which historically is the weakest period due to the summer slowdown, particularly in our UK healthcare business. This was as a result of delays in contracts closing, not competitive losses, and therefore the current pipeline for new business wins and licence renewals remains strong. The timing will have a knock-on effect on implementation and support revenues in the current quarter.

 

Progress in our growing portfolio of subscription-based product lines has been encouraging, with a number of these performing above management expectation, most notably our new Allocate Cloud service which we launched during the first quarter. It is however a function of the subscription model that the revenues from new business wins, recognised rateably over an extended period, will not significantly offset the impact of reduced licence and services revenues in the first half, though it does provide a more secure basis for the business in the longer term.

 

As a result of these factors and the changing business mix, the Board now expects that first half revenues will be lower than its original expectations, albeit broadly in line with the first half of the last financial year, and EBITDA will be below the prior year first half comparable.

 

Ian Bowles, Chief Executive, commented: "The Board continues to believe that the Company's new business pipeline and prospects remain strong, and will continue to drive the business towards meeting its financial targets for the full year. Whilst it is not possible to be certain that the first half revenue shortfall will be fully recouped in the second half, any resulting impact on profits will likely be mitigated by tight control over operating expenditure."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Simon Willis /

Richard Thomas

Corporate Broking - James Black

 

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.Allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAAURURARRAA
Date   Source Headline
3rd Mar 20091:49 pmRNSAward of Contracts
4th Feb 20091:25 pmRNSHolding(s) in Company
21st Jan 20097:00 amRNSInterim Results
15th Jan 200911:58 amRNSHolding(s) in Company
19th Dec 200810:58 amRNSResult of AGM
10th Dec 20087:00 amRNSAcquisition of Baum Hart & Partners
1st Dec 20087:00 amRNSAward of Contracts
21st Nov 20084:32 pmRNSAnnual Report and Accounts
28th Oct 20087:00 amRNSHolding(s) in Company
1st Oct 20086:16 pmRNSHolding(s) in Company
1st Oct 20083:10 pmRNSHolding(s) in Company
17th Sep 20084:32 pmRNSHolding(s) in Company
10th Sep 20083:44 pmRNSHolding(s) in Company
8th Sep 20087:00 amRNSAward of contracts
28th Jul 20087:00 amRNSFinal Results
15th Jul 20085:43 pmRNSHolding(s) in Company
30th Jun 20087:00 amRNSDirectorate Change
10th Jun 20087:00 amRNSAward of Contract
2nd Jun 20087:00 amRNSAward of Contracts
27th May 20089:34 amRNSDirector/PDMR Shareholding
22nd May 20087:00 amRNSAward of Contract
6th May 20087:02 amRNSAward of Directors' Options
2nd May 20087:00 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSAcquisition
4th Apr 20087:01 amRNSTrading Statement
26th Mar 20088:00 amRNSAward of Contract
17th Mar 20087:00 amRNSAward of Contract
10th Mar 20087:00 amRNSAward of Contract
4th Mar 20087:00 amRNSAward of Contract
28th Feb 20089:01 amRNSExercise of Share Options
26th Feb 20087:00 amRNSAward of Contract
21st Feb 20087:00 amRNSAward of Contract
6th Feb 20087:01 amRNSInterim Results
4th Feb 20087:01 amRNSAward of Contract
31st Jan 20087:00 amRNSAward of Contract
22nd Jan 20087:00 amRNSAward of Contract
18th Jan 20087:01 amRNSAward of Contract
17th Jan 20087:00 amRNSHolding(s) in Company
15th Jan 200812:06 pmRNSHolding(s) in Company
4th Jan 20089:38 amRNSTotal Voting Rights
4th Jan 20087:00 amRNSAward of Contract
4th Jan 20087:00 amRNSAward of Contract
3rd Jan 20088:46 amRNSAward of Contract
20th Dec 20077:01 amRNSAGM Statement
12th Dec 200711:13 amRNSHolding(s) in Company
11th Dec 20077:00 amRNSCorrection: Holdings in Co.
10th Dec 20074:43 pmRNSHolding(s) in Company
3rd Dec 200711:30 amRNSDirector/PDMR Shareholding
29th Nov 20077:01 amRNSCirc re. contract extension
21st Nov 20077:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.